Global Meningococcal Vaccine Market Research Report 2024(Status and Outlook)
![](/report_cover/11711/global-meningococcal-vaccine-market-research-report-2022status-n-outlook_en.gif)
Report Overview:
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
The Global Meningococcal Vaccine Market Size was estimated at USD 275.06 million in 2023 and is projected to reach USD 356.15 million by 2029, exhibiting a CAGR of 4.40% during the forecast period.
This report provides a deep insight into the global Meningococcal Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Meningococcal Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Meningococcal Vaccine market in any manner.
Global Meningococcal Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
Market Segmentation (by Type)
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
Market Segmentation (by Application)
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningococcal Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Meningococcal vaccine refers to any of the vaccines used to prevent infection by Neisseria meningitides. The vaccines are between 85 and 100% effective for at least two years. They result in a decrease in meningitis and sepsis among populations where they are widely used. They are given either by injection into a muscle or just under the skin.
The Global Meningococcal Vaccine Market Size was estimated at USD 275.06 million in 2023 and is projected to reach USD 356.15 million by 2029, exhibiting a CAGR of 4.40% during the forecast period.
This report provides a deep insight into the global Meningococcal Vaccine market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Meningococcal Vaccine Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Meningococcal Vaccine market in any manner.
Global Meningococcal Vaccine Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Novartis
GSK
Merck
CSL
Baxter
JN International Medical Corporation
Serum Institute of India
Bio-Med
China National Biotec Group
Hualan Bio
Walvax
Zhifei
Market Segmentation (by Type)
Meningtits A
Polysaccharide Meningtitis AC
Meningitis ACYW
Market Segmentation (by Application)
6 Months-15Year
over 3 Year
over 2 Year
over 3 Months
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Meningococcal Vaccine Market
- Overview of the regional outlook of the Meningococcal Vaccine Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Note: this report may need to undergo a final check or review and this could take about 48 hours.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Meningococcal Vaccine Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Meningococcal Vaccine
1.2 Key Market Segments
1.2.1 Meningococcal Vaccine Segment by Type
1.2.2 Meningococcal Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MENINGOCOCCAL VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Meningococcal Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Meningococcal Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MENINGOCOCCAL VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Meningococcal Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Meningococcal Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Meningococcal Vaccine Sales Sites, Area Served, Product Type
3.6 Meningococcal Vaccine Market Competitive Situation and Trends
3.6.1 Meningococcal Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Meningococcal Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MENINGOCOCCAL VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Meningococcal Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MENINGOCOCCAL VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Meningococcal Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Meningococcal Vaccine Price by Type (2019-2024)
7 MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Vaccine Market Sales by Application (2019-2024)
7.3 Global Meningococcal Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Meningococcal Vaccine Sales Growth Rate by Application (2019-2024)
8 MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Meningococcal Vaccine Sales by Region
8.1.1 Global Meningococcal Vaccine Sales by Region
8.1.2 Global Meningococcal Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Meningococcal Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Meningococcal Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Meningococcal Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Meningococcal Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Meningococcal Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Novartis
9.1.1 Novartis Meningococcal Vaccine Basic Information
9.1.2 Novartis Meningococcal Vaccine Product Overview
9.1.3 Novartis Meningococcal Vaccine Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Meningococcal Vaccine SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 GSK
9.2.1 GSK Meningococcal Vaccine Basic Information
9.2.2 GSK Meningococcal Vaccine Product Overview
9.2.3 GSK Meningococcal Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Meningococcal Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Merck
9.3.1 Merck Meningococcal Vaccine Basic Information
9.3.2 Merck Meningococcal Vaccine Product Overview
9.3.3 Merck Meningococcal Vaccine Product Market Performance
9.3.4 Merck Meningococcal Vaccine SWOT Analysis
9.3.5 Merck Business Overview
9.3.6 Merck Recent Developments
9.4 CSL
9.4.1 CSL Meningococcal Vaccine Basic Information
9.4.2 CSL Meningococcal Vaccine Product Overview
9.4.3 CSL Meningococcal Vaccine Product Market Performance
9.4.4 CSL Business Overview
9.4.5 CSL Recent Developments
9.5 Baxter
9.5.1 Baxter Meningococcal Vaccine Basic Information
9.5.2 Baxter Meningococcal Vaccine Product Overview
9.5.3 Baxter Meningococcal Vaccine Product Market Performance
9.5.4 Baxter Business Overview
9.5.5 Baxter Recent Developments
9.6 JN International Medical Corporation
9.6.1 JN International Medical Corporation Meningococcal Vaccine Basic Information
9.6.2 JN International Medical Corporation Meningococcal Vaccine Product Overview
9.6.3 JN International Medical Corporation Meningococcal Vaccine Product Market Performance
9.6.4 JN International Medical Corporation Business Overview
9.6.5 JN International Medical Corporation Recent Developments
9.7 Serum Institute of India
9.7.1 Serum Institute of India Meningococcal Vaccine Basic Information
9.7.2 Serum Institute of India Meningococcal Vaccine Product Overview
9.7.3 Serum Institute of India Meningococcal Vaccine Product Market Performance
9.7.4 Serum Institute of India Business Overview
9.7.5 Serum Institute of India Recent Developments
9.8 Bio-Med
9.8.1 Bio-Med Meningococcal Vaccine Basic Information
9.8.2 Bio-Med Meningococcal Vaccine Product Overview
9.8.3 Bio-Med Meningococcal Vaccine Product Market Performance
9.8.4 Bio-Med Business Overview
9.8.5 Bio-Med Recent Developments
9.9 China National Biotec Group
9.9.1 China National Biotec Group Meningococcal Vaccine Basic Information
9.9.2 China National Biotec Group Meningococcal Vaccine Product Overview
9.9.3 China National Biotec Group Meningococcal Vaccine Product Market Performance
9.9.4 China National Biotec Group Business Overview
9.9.5 China National Biotec Group Recent Developments
9.10 Hualan Bio
9.10.1 Hualan Bio Meningococcal Vaccine Basic Information
9.10.2 Hualan Bio Meningococcal Vaccine Product Overview
9.10.3 Hualan Bio Meningococcal Vaccine Product Market Performance
9.10.4 Hualan Bio Business Overview
9.10.5 Hualan Bio Recent Developments
9.11 Walvax
9.11.1 Walvax Meningococcal Vaccine Basic Information
9.11.2 Walvax Meningococcal Vaccine Product Overview
9.11.3 Walvax Meningococcal Vaccine Product Market Performance
9.11.4 Walvax Business Overview
9.11.5 Walvax Recent Developments
9.12 Zhifei
9.12.1 Zhifei Meningococcal Vaccine Basic Information
9.12.2 Zhifei Meningococcal Vaccine Product Overview
9.12.3 Zhifei Meningococcal Vaccine Product Market Performance
9.12.4 Zhifei Business Overview
9.12.5 Zhifei Recent Developments
10 MENINGOCOCCAL VACCINE MARKET FORECAST BY REGION
10.1 Global Meningococcal Vaccine Market Size Forecast
10.2 Global Meningococcal Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Meningococcal Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Meningococcal Vaccine Market Size Forecast by Region
10.2.4 South America Meningococcal Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Meningococcal Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Meningococcal Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Meningococcal Vaccine by Type (2025-2030)
11.1.2 Global Meningococcal Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Meningococcal Vaccine by Type (2025-2030)
11.2 Global Meningococcal Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Meningococcal Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Meningococcal Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Meningococcal Vaccine
1.2 Key Market Segments
1.2.1 Meningococcal Vaccine Segment by Type
1.2.2 Meningococcal Vaccine Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 MENINGOCOCCAL VACCINE MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Meningococcal Vaccine Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Meningococcal Vaccine Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 MENINGOCOCCAL VACCINE MARKET COMPETITIVE LANDSCAPE
3.1 Global Meningococcal Vaccine Sales by Manufacturers (2019-2024)
3.2 Global Meningococcal Vaccine Revenue Market Share by Manufacturers (2019-2024)
3.3 Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Meningococcal Vaccine Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Meningococcal Vaccine Sales Sites, Area Served, Product Type
3.6 Meningococcal Vaccine Market Competitive Situation and Trends
3.6.1 Meningococcal Vaccine Market Concentration Rate
3.6.2 Global 5 and 10 Largest Meningococcal Vaccine Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 MENINGOCOCCAL VACCINE INDUSTRY CHAIN ANALYSIS
4.1 Meningococcal Vaccine Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF MENINGOCOCCAL VACCINE MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Meningococcal Vaccine Sales Market Share by Type (2019-2024)
6.3 Global Meningococcal Vaccine Market Size Market Share by Type (2019-2024)
6.4 Global Meningococcal Vaccine Price by Type (2019-2024)
7 MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Meningococcal Vaccine Market Sales by Application (2019-2024)
7.3 Global Meningococcal Vaccine Market Size (M USD) by Application (2019-2024)
7.4 Global Meningococcal Vaccine Sales Growth Rate by Application (2019-2024)
8 MENINGOCOCCAL VACCINE MARKET SEGMENTATION BY REGION
8.1 Global Meningococcal Vaccine Sales by Region
8.1.1 Global Meningococcal Vaccine Sales by Region
8.1.2 Global Meningococcal Vaccine Sales Market Share by Region
8.2 North America
8.2.1 North America Meningococcal Vaccine Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Meningococcal Vaccine Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Meningococcal Vaccine Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Meningococcal Vaccine Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Meningococcal Vaccine Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 KEY COMPANIES PROFILE
9.1 Novartis
9.1.1 Novartis Meningococcal Vaccine Basic Information
9.1.2 Novartis Meningococcal Vaccine Product Overview
9.1.3 Novartis Meningococcal Vaccine Product Market Performance
9.1.4 Novartis Business Overview
9.1.5 Novartis Meningococcal Vaccine SWOT Analysis
9.1.6 Novartis Recent Developments
9.2 GSK
9.2.1 GSK Meningococcal Vaccine Basic Information
9.2.2 GSK Meningococcal Vaccine Product Overview
9.2.3 GSK Meningococcal Vaccine Product Market Performance
9.2.4 GSK Business Overview
9.2.5 GSK Meningococcal Vaccine SWOT Analysis
9.2.6 GSK Recent Developments
9.3 Merck
9.3.1 Merck Meningococcal Vaccine Basic Information
9.3.2 Merck Meningococcal Vaccine Product Overview
9.3.3 Merck Meningococcal Vaccine Product Market Performance
9.3.4 Merck Meningococcal Vaccine SWOT Analysis
9.3.5 Merck Business Overview
9.3.6 Merck Recent Developments
9.4 CSL
9.4.1 CSL Meningococcal Vaccine Basic Information
9.4.2 CSL Meningococcal Vaccine Product Overview
9.4.3 CSL Meningococcal Vaccine Product Market Performance
9.4.4 CSL Business Overview
9.4.5 CSL Recent Developments
9.5 Baxter
9.5.1 Baxter Meningococcal Vaccine Basic Information
9.5.2 Baxter Meningococcal Vaccine Product Overview
9.5.3 Baxter Meningococcal Vaccine Product Market Performance
9.5.4 Baxter Business Overview
9.5.5 Baxter Recent Developments
9.6 JN International Medical Corporation
9.6.1 JN International Medical Corporation Meningococcal Vaccine Basic Information
9.6.2 JN International Medical Corporation Meningococcal Vaccine Product Overview
9.6.3 JN International Medical Corporation Meningococcal Vaccine Product Market Performance
9.6.4 JN International Medical Corporation Business Overview
9.6.5 JN International Medical Corporation Recent Developments
9.7 Serum Institute of India
9.7.1 Serum Institute of India Meningococcal Vaccine Basic Information
9.7.2 Serum Institute of India Meningococcal Vaccine Product Overview
9.7.3 Serum Institute of India Meningococcal Vaccine Product Market Performance
9.7.4 Serum Institute of India Business Overview
9.7.5 Serum Institute of India Recent Developments
9.8 Bio-Med
9.8.1 Bio-Med Meningococcal Vaccine Basic Information
9.8.2 Bio-Med Meningococcal Vaccine Product Overview
9.8.3 Bio-Med Meningococcal Vaccine Product Market Performance
9.8.4 Bio-Med Business Overview
9.8.5 Bio-Med Recent Developments
9.9 China National Biotec Group
9.9.1 China National Biotec Group Meningococcal Vaccine Basic Information
9.9.2 China National Biotec Group Meningococcal Vaccine Product Overview
9.9.3 China National Biotec Group Meningococcal Vaccine Product Market Performance
9.9.4 China National Biotec Group Business Overview
9.9.5 China National Biotec Group Recent Developments
9.10 Hualan Bio
9.10.1 Hualan Bio Meningococcal Vaccine Basic Information
9.10.2 Hualan Bio Meningococcal Vaccine Product Overview
9.10.3 Hualan Bio Meningococcal Vaccine Product Market Performance
9.10.4 Hualan Bio Business Overview
9.10.5 Hualan Bio Recent Developments
9.11 Walvax
9.11.1 Walvax Meningococcal Vaccine Basic Information
9.11.2 Walvax Meningococcal Vaccine Product Overview
9.11.3 Walvax Meningococcal Vaccine Product Market Performance
9.11.4 Walvax Business Overview
9.11.5 Walvax Recent Developments
9.12 Zhifei
9.12.1 Zhifei Meningococcal Vaccine Basic Information
9.12.2 Zhifei Meningococcal Vaccine Product Overview
9.12.3 Zhifei Meningococcal Vaccine Product Market Performance
9.12.4 Zhifei Business Overview
9.12.5 Zhifei Recent Developments
10 MENINGOCOCCAL VACCINE MARKET FORECAST BY REGION
10.1 Global Meningococcal Vaccine Market Size Forecast
10.2 Global Meningococcal Vaccine Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Meningococcal Vaccine Market Size Forecast by Country
10.2.3 Asia Pacific Meningococcal Vaccine Market Size Forecast by Region
10.2.4 South America Meningococcal Vaccine Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Meningococcal Vaccine by Country
11 FORECAST MARKET BY TYPE AND BY APPLICATION (2025-2030)
11.1 Global Meningococcal Vaccine Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Meningococcal Vaccine by Type (2025-2030)
11.1.2 Global Meningococcal Vaccine Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Meningococcal Vaccine by Type (2025-2030)
11.2 Global Meningococcal Vaccine Market Forecast by Application (2025-2030)
11.2.1 Global Meningococcal Vaccine Sales (Kilotons) Forecast by Application
11.2.2 Global Meningococcal Vaccine Market Size (M USD) Forecast by Application (2025-2030)
12 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Meningococcal Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Meningococcal Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Meningococcal Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Meningococcal Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Meningococcal Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2022)
Table 10. Global Market Meningococcal Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Meningococcal Vaccine Sales Sites and Area Served
Table 12. Manufacturers Meningococcal Vaccine Product Type
Table 13. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Meningococcal Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Meningococcal Vaccine Market Challenges
Table 22. Global Meningococcal Vaccine Sales by Type (Kilotons)
Table 23. Global Meningococcal Vaccine Market Size by Type (M USD)
Table 24. Global Meningococcal Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Meningococcal Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Meningococcal Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Meningococcal Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Meningococcal Vaccine Sales (Kilotons) by Application
Table 30. Global Meningococcal Vaccine Market Size by Application
Table 31. Global Meningococcal Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Meningococcal Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Meningococcal Vaccine Market Share by Application (2019-2024)
Table 35. Global Meningococcal Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Meningococcal Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Meningococcal Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Meningococcal Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Meningococcal Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Meningococcal Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Meningococcal Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Meningococcal Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Novartis Meningococcal Vaccine Basic Information
Table 44. Novartis Meningococcal Vaccine Product Overview
Table 45. Novartis Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Novartis Business Overview
Table 47. Novartis Meningococcal Vaccine SWOT Analysis
Table 48. Novartis Recent Developments
Table 49. GSK Meningococcal Vaccine Basic Information
Table 50. GSK Meningococcal Vaccine Product Overview
Table 51. GSK Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Meningococcal Vaccine SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Merck Meningococcal Vaccine Basic Information
Table 56. Merck Meningococcal Vaccine Product Overview
Table 57. Merck Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck Meningococcal Vaccine SWOT Analysis
Table 59. Merck Business Overview
Table 60. Merck Recent Developments
Table 61. CSL Meningococcal Vaccine Basic Information
Table 62. CSL Meningococcal Vaccine Product Overview
Table 63. CSL Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. CSL Business Overview
Table 65. CSL Recent Developments
Table 66. Baxter Meningococcal Vaccine Basic Information
Table 67. Baxter Meningococcal Vaccine Product Overview
Table 68. Baxter Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Baxter Business Overview
Table 70. Baxter Recent Developments
Table 71. JN International Medical Corporation Meningococcal Vaccine Basic Information
Table 72. JN International Medical Corporation Meningococcal Vaccine Product Overview
Table 73. JN International Medical Corporation Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. JN International Medical Corporation Business Overview
Table 75. JN International Medical Corporation Recent Developments
Table 76. Serum Institute of India Meningococcal Vaccine Basic Information
Table 77. Serum Institute of India Meningococcal Vaccine Product Overview
Table 78. Serum Institute of India Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Serum Institute of India Business Overview
Table 80. Serum Institute of India Recent Developments
Table 81. Bio-Med Meningococcal Vaccine Basic Information
Table 82. Bio-Med Meningococcal Vaccine Product Overview
Table 83. Bio-Med Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bio-Med Business Overview
Table 85. Bio-Med Recent Developments
Table 86. China National Biotec Group Meningococcal Vaccine Basic Information
Table 87. China National Biotec Group Meningococcal Vaccine Product Overview
Table 88. China National Biotec Group Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. China National Biotec Group Business Overview
Table 90. China National Biotec Group Recent Developments
Table 91. Hualan Bio Meningococcal Vaccine Basic Information
Table 92. Hualan Bio Meningococcal Vaccine Product Overview
Table 93. Hualan Bio Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Hualan Bio Business Overview
Table 95. Hualan Bio Recent Developments
Table 96. Walvax Meningococcal Vaccine Basic Information
Table 97. Walvax Meningococcal Vaccine Product Overview
Table 98. Walvax Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Walvax Business Overview
Table 100. Walvax Recent Developments
Table 101. Zhifei Meningococcal Vaccine Basic Information
Table 102. Zhifei Meningococcal Vaccine Product Overview
Table 103. Zhifei Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Zhifei Business Overview
Table 105. Zhifei Recent Developments
Table 106. Global Meningococcal Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Meningococcal Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Meningococcal Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Meningococcal Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Meningococcal Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Meningococcal Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Meningococcal Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Meningococcal Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Meningococcal Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Meningococcal Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Meningococcal Vaccine Market Size Comparison by Region (M USD)
Table 5. Global Meningococcal Vaccine Sales (Kilotons) by Manufacturers (2019-2024)
Table 6. Global Meningococcal Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 7. Global Meningococcal Vaccine Revenue (M USD) by Manufacturers (2019-2024)
Table 8. Global Meningococcal Vaccine Revenue Share by Manufacturers (2019-2024)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningococcal Vaccine as of 2022)
Table 10. Global Market Meningococcal Vaccine Average Price (USD/Ton) of Key Manufacturers (2019-2024)
Table 11. Manufacturers Meningococcal Vaccine Sales Sites and Area Served
Table 12. Manufacturers Meningococcal Vaccine Product Type
Table 13. Global Meningococcal Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Meningococcal Vaccine
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Meningococcal Vaccine Market Challenges
Table 22. Global Meningococcal Vaccine Sales by Type (Kilotons)
Table 23. Global Meningococcal Vaccine Market Size by Type (M USD)
Table 24. Global Meningococcal Vaccine Sales (Kilotons) by Type (2019-2024)
Table 25. Global Meningococcal Vaccine Sales Market Share by Type (2019-2024)
Table 26. Global Meningococcal Vaccine Market Size (M USD) by Type (2019-2024)
Table 27. Global Meningococcal Vaccine Market Size Share by Type (2019-2024)
Table 28. Global Meningococcal Vaccine Price (USD/Ton) by Type (2019-2024)
Table 29. Global Meningococcal Vaccine Sales (Kilotons) by Application
Table 30. Global Meningococcal Vaccine Market Size by Application
Table 31. Global Meningococcal Vaccine Sales by Application (2019-2024) & (Kilotons)
Table 32. Global Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Table 33. Global Meningococcal Vaccine Sales by Application (2019-2024) & (M USD)
Table 34. Global Meningococcal Vaccine Market Share by Application (2019-2024)
Table 35. Global Meningococcal Vaccine Sales Growth Rate by Application (2019-2024)
Table 36. Global Meningococcal Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 37. Global Meningococcal Vaccine Sales Market Share by Region (2019-2024)
Table 38. North America Meningococcal Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 39. Europe Meningococcal Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 40. Asia Pacific Meningococcal Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 41. South America Meningococcal Vaccine Sales by Country (2019-2024) & (Kilotons)
Table 42. Middle East and Africa Meningococcal Vaccine Sales by Region (2019-2024) & (Kilotons)
Table 43. Novartis Meningococcal Vaccine Basic Information
Table 44. Novartis Meningococcal Vaccine Product Overview
Table 45. Novartis Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 46. Novartis Business Overview
Table 47. Novartis Meningococcal Vaccine SWOT Analysis
Table 48. Novartis Recent Developments
Table 49. GSK Meningococcal Vaccine Basic Information
Table 50. GSK Meningococcal Vaccine Product Overview
Table 51. GSK Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 52. GSK Business Overview
Table 53. GSK Meningococcal Vaccine SWOT Analysis
Table 54. GSK Recent Developments
Table 55. Merck Meningococcal Vaccine Basic Information
Table 56. Merck Meningococcal Vaccine Product Overview
Table 57. Merck Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 58. Merck Meningococcal Vaccine SWOT Analysis
Table 59. Merck Business Overview
Table 60. Merck Recent Developments
Table 61. CSL Meningococcal Vaccine Basic Information
Table 62. CSL Meningococcal Vaccine Product Overview
Table 63. CSL Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 64. CSL Business Overview
Table 65. CSL Recent Developments
Table 66. Baxter Meningococcal Vaccine Basic Information
Table 67. Baxter Meningococcal Vaccine Product Overview
Table 68. Baxter Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 69. Baxter Business Overview
Table 70. Baxter Recent Developments
Table 71. JN International Medical Corporation Meningococcal Vaccine Basic Information
Table 72. JN International Medical Corporation Meningococcal Vaccine Product Overview
Table 73. JN International Medical Corporation Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 74. JN International Medical Corporation Business Overview
Table 75. JN International Medical Corporation Recent Developments
Table 76. Serum Institute of India Meningococcal Vaccine Basic Information
Table 77. Serum Institute of India Meningococcal Vaccine Product Overview
Table 78. Serum Institute of India Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 79. Serum Institute of India Business Overview
Table 80. Serum Institute of India Recent Developments
Table 81. Bio-Med Meningococcal Vaccine Basic Information
Table 82. Bio-Med Meningococcal Vaccine Product Overview
Table 83. Bio-Med Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 84. Bio-Med Business Overview
Table 85. Bio-Med Recent Developments
Table 86. China National Biotec Group Meningococcal Vaccine Basic Information
Table 87. China National Biotec Group Meningococcal Vaccine Product Overview
Table 88. China National Biotec Group Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 89. China National Biotec Group Business Overview
Table 90. China National Biotec Group Recent Developments
Table 91. Hualan Bio Meningococcal Vaccine Basic Information
Table 92. Hualan Bio Meningococcal Vaccine Product Overview
Table 93. Hualan Bio Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 94. Hualan Bio Business Overview
Table 95. Hualan Bio Recent Developments
Table 96. Walvax Meningococcal Vaccine Basic Information
Table 97. Walvax Meningococcal Vaccine Product Overview
Table 98. Walvax Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 99. Walvax Business Overview
Table 100. Walvax Recent Developments
Table 101. Zhifei Meningococcal Vaccine Basic Information
Table 102. Zhifei Meningococcal Vaccine Product Overview
Table 103. Zhifei Meningococcal Vaccine Sales (Kilotons), Revenue (M USD), Price (USD/Ton) and Gross Margin (2019-2024)
Table 104. Zhifei Business Overview
Table 105. Zhifei Recent Developments
Table 106. Global Meningococcal Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 107. Global Meningococcal Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 108. North America Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 109. North America Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 110. Europe Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 111. Europe Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 112. Asia Pacific Meningococcal Vaccine Sales Forecast by Region (2025-2030) & (Kilotons)
Table 113. Asia Pacific Meningococcal Vaccine Market Size Forecast by Region (2025-2030) & (M USD)
Table 114. South America Meningococcal Vaccine Sales Forecast by Country (2025-2030) & (Kilotons)
Table 115. South America Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 116. Middle East and Africa Meningococcal Vaccine Consumption Forecast by Country (2025-2030) & (Units)
Table 117. Middle East and Africa Meningococcal Vaccine Market Size Forecast by Country (2025-2030) & (M USD)
Table 118. Global Meningococcal Vaccine Sales Forecast by Type (2025-2030) & (Kilotons)
Table 119. Global Meningococcal Vaccine Market Size Forecast by Type (2025-2030) & (M USD)
Table 120. Global Meningococcal Vaccine Price Forecast by Type (2025-2030) & (USD/Ton)
Table 121. Global Meningococcal Vaccine Sales (Kilotons) Forecast by Application (2025-2030)
Table 122. Global Meningococcal Vaccine Market Size Forecast by Application (2025-2030) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Meningococcal Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningococcal Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Meningococcal Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Meningococcal Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningococcal Vaccine Market Size by Country (M USD)
Figure 11. Meningococcal Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Meningococcal Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Meningococcal Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Meningococcal Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Meningococcal Vaccine Market Share by Type
Figure 18. Sales Market Share of Meningococcal Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Meningococcal Vaccine by Type in 2023
Figure 20. Market Size Share of Meningococcal Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Meningococcal Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Meningococcal Vaccine Market Share by Application
Figure 24. Global Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Meningococcal Vaccine Sales Market Share by Application in 2023
Figure 26. Global Meningococcal Vaccine Market Share by Application (2019-2024)
Figure 27. Global Meningococcal Vaccine Market Share by Application in 2023
Figure 28. Global Meningococcal Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Meningococcal Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Meningococcal Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Meningococcal Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Meningococcal Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Meningococcal Vaccine Sales Market Share by Region in 2023
Figure 44. China Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Meningococcal Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Meningococcal Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Meningococcal Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Meningococcal Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Meningococcal Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Meningococcal Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Meningococcal Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Meningococcal Vaccine Market Share Forecast by Application (2025-2030)
Figure 1. Product Picture of Meningococcal Vaccine
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Meningococcal Vaccine Market Size (M USD), 2019-2030
Figure 5. Global Meningococcal Vaccine Market Size (M USD) (2019-2030)
Figure 6. Global Meningococcal Vaccine Sales (Kilotons) & (2019-2030)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Meningococcal Vaccine Market Size by Country (M USD)
Figure 11. Meningococcal Vaccine Sales Share by Manufacturers in 2023
Figure 12. Global Meningococcal Vaccine Revenue Share by Manufacturers in 2023
Figure 13. Meningococcal Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Meningococcal Vaccine Average Price (USD/Ton) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Meningococcal Vaccine Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Meningococcal Vaccine Market Share by Type
Figure 18. Sales Market Share of Meningococcal Vaccine by Type (2019-2024)
Figure 19. Sales Market Share of Meningococcal Vaccine by Type in 2023
Figure 20. Market Size Share of Meningococcal Vaccine by Type (2019-2024)
Figure 21. Market Size Market Share of Meningococcal Vaccine by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Meningococcal Vaccine Market Share by Application
Figure 24. Global Meningococcal Vaccine Sales Market Share by Application (2019-2024)
Figure 25. Global Meningococcal Vaccine Sales Market Share by Application in 2023
Figure 26. Global Meningococcal Vaccine Market Share by Application (2019-2024)
Figure 27. Global Meningococcal Vaccine Market Share by Application in 2023
Figure 28. Global Meningococcal Vaccine Sales Growth Rate by Application (2019-2024)
Figure 29. Global Meningococcal Vaccine Sales Market Share by Region (2019-2024)
Figure 30. North America Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 31. North America Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 32. U.S. Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 33. Canada Meningococcal Vaccine Sales (Kilotons) and Growth Rate (2019-2024)
Figure 34. Mexico Meningococcal Vaccine Sales (Units) and Growth Rate (2019-2024)
Figure 35. Europe Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 36. Europe Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 37. Germany Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 38. France Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 39. U.K. Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 40. Italy Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 41. Russia Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 42. Asia Pacific Meningococcal Vaccine Sales and Growth Rate (Kilotons)
Figure 43. Asia Pacific Meningococcal Vaccine Sales Market Share by Region in 2023
Figure 44. China Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 45. Japan Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 46. South Korea Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 47. India Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 48. Southeast Asia Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 49. South America Meningococcal Vaccine Sales and Growth Rate (Kilotons)
Figure 50. South America Meningococcal Vaccine Sales Market Share by Country in 2023
Figure 51. Brazil Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 52. Argentina Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 53. Columbia Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 54. Middle East and Africa Meningococcal Vaccine Sales and Growth Rate (Kilotons)
Figure 55. Middle East and Africa Meningococcal Vaccine Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 57. UAE Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 58. Egypt Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 59. Nigeria Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 60. South Africa Meningococcal Vaccine Sales and Growth Rate (2019-2024) & (Kilotons)
Figure 61. Global Meningococcal Vaccine Sales Forecast by Volume (2019-2030) & (Kilotons)
Figure 62. Global Meningococcal Vaccine Market Size Forecast by Value (2019-2030) & (M USD)
Figure 63. Global Meningococcal Vaccine Sales Market Share Forecast by Type (2025-2030)
Figure 64. Global Meningococcal Vaccine Market Share Forecast by Type (2025-2030)
Figure 65. Global Meningococcal Vaccine Sales Forecast by Application (2025-2030)
Figure 66. Global Meningococcal Vaccine Market Share Forecast by Application (2025-2030)